Trial intelligence / Profile preview

Opioids vs Acetaminophen for Moderate Persistent Non-cancer Pain

NCT01264965Phase 4Terminated

Sponsor
University of Chicago
Start
Jan 2011
Primary completion
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of oxycodone in osteoarthritis (OA) (2 arms), sponsored by University of Chicago. Primary endpoint: Pain Self-report on the Brief Pain Inventory and WOMAC at 14 days. Started Jan 2011; status: terminated.

02

Drugs

oxycodone
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01264965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01264965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call